Financial statements Inpharm Spółka Z Ograniczoną Odpowiedzialnością
Balance sheet data of INPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 12 105 638,19 | 10 692 457,39 | 10 904 721,14 | 15 120 650,33 | 14 885 302,64 | 16 829 826,77 |
| A. Fixed assets | 9 855 995,32 | 9 668 152,39 | 10 340 502,50 | 10 465 878,16 | 11 691 534,90 | 11 136 185,86 |
| B. Current assets | 2 249 642,87 | 1 024 305,00 | 564 218,64 | 4 654 772,17 | 3 193 767,74 | 5 693 640,91 |
| C. Share capital contributions (basic funds) | - | - | 0,00 | 0,00 | - | 0,00 |
| D. Own shares (stocks) | - | - | 0,00 | 0,00 | - | 0,00 |
| Total liabilities | 12 105 638,19 | 10 692 457,39 | 10 904 721,14 | 15 120 650,33 | 14 885 302,64 | 16 829 826,77 |
| A. Equity | 4 282 167,06 | 3 977 774,48 | 3 226 630,75 | 4 701 261,28 | 2 961 221,15 | 4 554 403,32 |
| B. Liabilities and provisions for liabilities | 7 823 471,13 | 6 714 682,91 | 7 678 090,39 | 10 419 389,05 | 11 924 081,49 | 12 275 423,45 |
| I. Long-term liabilities | 5 504 000,00 | 4 472 000,00 | 2 408 000,00 | 1 769 939,40 | 374 303,04 | 0,00 |
| II. Short-term liabilities | 2 192 795,87 | 1 999 220,20 | 5 022 361,65 | 8 410 089,44 | 11 394 792,14 | 12 265 962,99 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.